Truist analyst Jailendra Singh raised the firm’s price target on Accolade to $16 from $15 and keeps a Buy rating on the shares. The technology investments made by the company in the past couple of years are starting to yield tangible results, and the management believes those kinds of drivers of value are starting to manifest in terms of benefits creation, benefits consumption, and data consumption, which provides the company with better visibility to the updated margin ramp, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACCD:
- Accolade Announces Results for Fiscal Third Quarter 2024
- Options Volatility and Implied Earnings Moves Today, January 08, 2024
- Options Volatility and Implied Earnings Moves This Week, January 08 – January 12, 2024
- Is ACCD a Buy, Before Earnings?
- Accolade price target lowered to $15 from $17 at Stifel
